Pardes Biosciences Appoints Deborah M. Autor, J.D. and Laura J. Hamill to Board of Directors

NEXT STORY
Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2021
PREV STORY
Madrigal Pharmaceuticals Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

DIAGNOS presents a technological showcase at the CHUM with the opening of an automated diabetic retinopathy screening clinic assisted by AI (Artificial Intelligence) with financial support of the Québec government

BROSSARD, Quebec, June 05, 2018 (GLOBE NEWSWIRE) -- DIAGNOS inc. (“DIAGNOS” or the “Company”) ...

author_avatar
NASDAQ Market News

HUTCHMED Announces First Commercial Sale of ORPATHYS® in China, Triggering a US$25 million Milestone Payment from AstraZeneca

author_avatar
NASDAQ Market News

CORRECTING and REPLACING — Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian Cancer

 Expert Advisory Board Endorses Randomized Phase I/II Trial in Newly Diagnosed Stage III and IV ...

author_avatar
NASDAQ Market News